These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 7510235

  • 1. Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression.
    Clements JL, Wolfe J, Cooper SM, Budd RC.
    Eur J Immunol; 1994 Mar; 24(3):558-65. PubMed ID: 7510235
    [Abstract] [Full Text] [Related]

  • 2. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.
    Budd RC, Russell JQ, van Houten N, Cooper SM, Yagita H, Wolfe J.
    J Immunol; 1992 Feb 15; 148(4):1055-64. PubMed ID: 1346621
    [Abstract] [Full Text] [Related]

  • 3. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
    Clements JL, Winslow G, Donahue C, Cooper SM, Allison JP, Budd RC.
    Int Immunol; 1993 Nov 15; 5(11):1451-60. PubMed ID: 7903158
    [Abstract] [Full Text] [Related]

  • 4. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
    Budd RC, Winslow G, Inokuchi S, Imboden JB.
    J Immunol; 1990 Nov 01; 145(9):2862-72. PubMed ID: 1976707
    [Abstract] [Full Text] [Related]

  • 5. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T, Allison JP, Davidson WF.
    J Immunol; 1993 Jul 15; 151(2):597-609. PubMed ID: 7687618
    [Abstract] [Full Text] [Related]

  • 6. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM, Van Houten N, Russell JQ, Scollay R, Parnes JR, Budd RC.
    J Immunol; 1993 Jul 15; 151(2):1086-96. PubMed ID: 7687614
    [Abstract] [Full Text] [Related]

  • 7. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
    Balomenos D, Rumold R, Theofilopoulos AN.
    J Immunol; 1997 Sep 01; 159(5):2265-73. PubMed ID: 9278315
    [Abstract] [Full Text] [Related]

  • 8. The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.
    Shirai T, Abe M, Yagita H, Okumura K, Morse HC, Davidson WF.
    J Immunol; 1990 May 15; 144(10):3756-61. PubMed ID: 1970592
    [Abstract] [Full Text] [Related]

  • 9. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK, Fujihashi K, Taguchi T, McGhee JR, Yamamoto M, Eldridge JH, Gay S, Kiyono H.
    Eur J Immunol; 1992 Jan 15; 22(1):137-45. PubMed ID: 1346108
    [Abstract] [Full Text] [Related]

  • 10. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.
    Giese T, Davidson WF.
    J Immunol; 1992 Nov 01; 149(9):3097-106. PubMed ID: 1383337
    [Abstract] [Full Text] [Related]

  • 11. Maturational changes in CD4+ cell subsets and lymphokine production in BXSB mice.
    Chu EB, Ernst DN, Hobbs MV, Weigle WO.
    J Immunol; 1994 Apr 15; 152(8):4129-38. PubMed ID: 7511669
    [Abstract] [Full Text] [Related]

  • 12. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [Abstract] [Full Text] [Related]

  • 13. Parallels in T lymphocyte development between lpr and normal mice.
    Budd RC, Van Houten N, Clements J, Mixter PF.
    Semin Immunol; 1994 Feb 15; 6(1):43-8. PubMed ID: 8167306
    [Abstract] [Full Text] [Related]

  • 14. The role of the interleukin-2 (IL-2)/IL-2 receptor pathway in MRL/lpr lymphadenopathy: the expanded CD4-8- T cell subset completely lacks functional IL-2 receptors.
    Tanaka T, Nagasaka Y, Kitamura F, Kuida K, Suwa H, Miyasaka M.
    Eur J Immunol; 1993 Jun 15; 23(6):1378-80. PubMed ID: 7684688
    [Abstract] [Full Text] [Related]

  • 15. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development.
    Chang JF, Thomas CA, Kung JT.
    J Immunol; 1991 Aug 01; 147(3):860-6. PubMed ID: 1830601
    [Abstract] [Full Text] [Related]

  • 16. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S, Yuan D, Katagiri T, Eisenberg RA, Cohen PL, Ting JP.
    J Immunol; 1987 Oct 15; 139(8):2810-7. PubMed ID: 3116095
    [Abstract] [Full Text] [Related]

  • 17. A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals.
    Mixter PF, Russell JQ, Morrissette GJ, Charland C, Aleman-Hoey D, Budd RC.
    J Immunol; 1999 May 15; 162(10):5747-56. PubMed ID: 10229807
    [Abstract] [Full Text] [Related]

  • 18. Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses.
    Asano T, Yoshikai Y, Matsumoto K, Matuzaki G, Nomoto K.
    Clin Exp Immunol; 1990 Jul 15; 81(1):90-6. PubMed ID: 1696186
    [Abstract] [Full Text] [Related]

  • 19. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T, Yagi T, Kakinuma S, Kurokawa A, Okada T, Takatsu K, Aizawa S, Katagiri T.
    J Immunol; 1997 Sep 01; 159(5):2532-41. PubMed ID: 9278347
    [Abstract] [Full Text] [Related]

  • 20. Abnormal regulation of the IL-2 promoter in lpr CD4-CD8- T lymphocytes results in constitutive expression of a novel nuclear factor of activated T cells-binding factor.
    Clements JL, Cooper SM, Budd RC.
    J Immunol; 1995 Jun 15; 154(12):6372-81. PubMed ID: 7759875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.